13F COMBINATION REPORT
DC Funds, LP
Quarter ended Q3 2023 · Filed August 10, 2023 · Accession 0001398344-23-014529
Total Value
$4.7M
Positions
3
Other Managers
0
Confidential Omitted
No
Holdings (3)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | WEREWOLF THERAPEUTICS INC | HOWL | 589,102 | $1.8M | 38.27% |
| 2 | TSCAN THERAPEUTICS INC | TCRX | 630,000 | $1.6M | 33.55% |
| 3 | VACCITECH PLC | BRNS | 642,204 | $1.3M | 28.18% |